If you think you may have been exposed to or gotten sick from the coronavirus that causes COVID-19, you can now get tested in the comfort of your living room. Quest Diagnostics on Thursday announced ...
Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that helps assess the potential risk of developing Alzheimer’s disease. In adding AD-Detect, a single-blood-draw ...
Quest Diagnostics has launched an at-home diagnostic test for COVID-19 that individuals can order online, but the out-of-pocket cost for the test could get in the way of widespread use. The test, ...
Quest Diagnostics is selling a direct-to-consumer antibody test that the company says will make it easy for people to check whether they may have been exposed to the coronavirus. After ordering the ...
Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...
GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK, Calif. and ...
Advances in drug treatments for Alzheimer’s disease have opened doors for diagnostics, and Quest is the latest to walk through. The clinical testing giant has put forward a blood test designed to help ...
In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and ...
SECAUCUS, N.J., April 9, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback